Release Date: 09/05/18 08:20 Summary: SEMI ANNUAL REPORT TO SHAREHOLDERS Price Sensitive: No Download Document 379.16KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status